WCS09 Dermatology 2 Flashcards
Dermatologic emergencies
- Eczema herpeticum
- Generalised Exofoliative Dermatitis (GED) / Erythroderma
- Bullous pemphigoid
- Pemphigus vulgaris
- Pustular psoriasis
- Acute Generalised Exanthematous Pustulosis (AGEP)
- Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)
- Stevens-Johnson syndrome (SJS) / Toxic Epidermal Necrolysis (TEN)
- Eczema herpeticum
Caused by ***Herpes virus
- starts with clusters of ***itchy / painful blisters (記: 好多細紅點)
- Face + Neck
- in normal skin / sites affected by Atopic dermatitis / other skin disease
- ***unwell, fever, swollen local LN
Complications:
1. Secondary bacterial infection
- Staphylococcus / Streptococcus—> Impetigo / Cellulitis
- Affect multiple organs
- eyes, brain, lung, liver
- rarely fatal
Management:
- IV ***Aciclovir 15 mg/kg/day for >= 5 days
- Generalised Exofoliative Dermatitis (GED) / Erythroderma
- Any ***inflammatory skin disease affecting >90% of body surface (記: 係咁甩皮 + 好紅)
- Not a defined entity, but a clinical presentation of a variety of diseases
Epidemiology:
- True incidence unknown: 0.9 per 100,000
- 50-60 years of age
- Male : Female = 2-4 : 1
Challenge:
- Identify cause
**Underlying causes:
1. **Pre-existing dermatoses (53%)
- **Atopic dermatitis
- **Psoriasis (Pustular flare)
- Contact dermatitis: Airborne / Phytophotocontact dermatitis
-
**Drug eruptions (5%)
- Antiepileptics
- Antihypertensive (Captopril, Furosemide)
- **Antibiotic (Penicillin, Sulphonamide)
- ***Allopurinol -
**Malignancy (16%)
- **Cutaneous T Cell Lymphoma CTCL (including Sezary syndrome) (most common)
- Hodgkin’s disease (2nd most common) - Miscellaneous (rare)
- Idiopathic (26%)
Investigations for GED
Basic investigations:
- Full blood count, ESR
- Peripheral blood film
- **Buffy coat for Sezary cells (for CTCL)
- Urea, creatinine, electrolytes
- LFT
- CXR
- **Skin biopsy for history (>=2 sites): Direct Immunofluorescence (DIF) if immunobullous disease suspected
- Age appropriate ***malignancy work-up
Management of GED
Monitor + Correct:
- **Protein / Electrolyte imbalance
- **Circulatory status (e.g. BP, pulse rate)
- **Body temperature
- **Secondary sepsis
Control:
- Environmental temperature (avoid over-cooling / heating)
- Adequate fluid intake
- Diuretics / Plasma infusion if edema. Treat cardiac failure
- Consider drug cause - stop non-essential drugs
- Treat secondary infections
- ***Intensive topicals
Treatment:
- Severe / Persistent / Idiopathic / Drug causes: Prednisolone 0.5-1 mg/kg/day
—> Beware pustulation if have concurrent **psoriasis (*Pustular flare during withdrawal)
Intensive topicals
Scalp:
- Cetrimide / Coal tar shampoo
- Betamethasone valerate 0.1% scalp lotion BD
Trunk:
- Betamethasone valerate 0.1% BD (cream if oozy, ointment if dry)
Face and Flexures:
- Betamethasone valerate 0.025% (∵ thin skin) cream BD
Skincare:
- Chlorhexadine / Potassium permanganate wash (if oozy / infected)
- Emulsifying ointment (if dry)
- White soft paraffin: Liquid paraffin TDS to body
- Aqueous cream BD to face
Double pajamas (Wet wrap)
- Bullous pemphigoid
More common:
- Men
- >60
Etiology:
1. **Drugs (younger average age than idiopathic group)
2. Local irritation / damage
3. **UV light + PUVA
4. ***Immunisation in children
Pathogenesis (Autoimmune mediated):
- IgG AutoAb bind to **Hemidesmosomal proteins (BP230, BP180)
- Bind to **Dermal-epidermal junction of skin
- Binding of IgG to BP180 + BP230
—> ***Complement activation
—> Inflammatory cascade
—> Inflammatory cells release Lysosomal enzymes + Proteases
—> cleaves target antigens + disrupt hemidesmosomes
—> Blistering
Clinical features (記: 好多Bulla):
1. Prodromal phase (may not have)
- ***itch, non-specific rash (Urticaria like)
- Acute phase
- acute generalised eruption of **blisters
- **Leukocytosis + ***Eosinophilia - Healing phase
- fluid in blisters reabsorbed
- Milia may be profuse
Mucosal lesions less frequent + less severe
Infants: Acral
Older children: Genital involvement in > 50%
Treatment of Bullous pemphigoid
- Suppress disease activity with minimum dose of drugs necessary
- Aim for presence of a blister once every few weeks
- ***Topical steroids (potent topicals)
- ***Systemic steroids
- Other systemic therapies
- Tetracyclines (e.g. Doxycycline + Nicotinamide)
- ***Dapsone (1st choice)
- Methotrexate (2nd choice)
- Azathioprine + Mycophenolate mofetil (3rd choice)
- IVIg / Rituximab
Immunosuppressant: beware TB, pneumonia, hepatitis
Steroid: monitor HbA1c
- Pemphigus vulgaris
Etiology:
- ***Drug-induced pemphigus: Pencillamine, Captopril
- Paraneoplastic pemphigus: associated with malignancy
Clinical presentation (記: 飛滋 + Bulla + 爛皮):
1. **Oral mucosal erosions
2. **Flaccid bullae
3. ***Cutaneous erosions
Serious bullous **autoimmune disease
- skin + mucous membrane
- start in mouth —> skin / generalised acute eruption of both
- **fatal unless treated with steroids + immunosuppressive aggressively
- painful mouth erosions (may affect food intake)
Age: 40-60
Pathophysiology:
- Autoimmune: AutoAb bind to **Desmoglein 3 + 1 (DSG 3, DSG 1) in **Epidermis intercellular layer
Variants:
- Pemphigus vegetans: **intertriginous areas (two skin areas touch or rub together) with vegetating lesions
- Pemphigus foliaceous: erythematous patches / erosions covered with **crustations
- Pemphigus erythematosus: erythematous crusted erosive lesions in ***butterfly area of face, forehead + chest, ANA +ve (related to SLE)
Management:
1. Correction of fluid + electrolyte loss
2. Antibiotics to treat infection
3. Systemic steroids
4. Immunosuppressive therapy (given with steroids)
- Azathioprine
- Methotrexate
- Cyclophosphamide
- Rituximab
- IVIg
- Pustular psoriasis
- Erythematous plaques studded with pustules
- 10% generalised pustular psoriasis have preceding psoriasis
Potential triggers:
1. **Sudden withdrawal of corticosteroids —> Pustular flare
2. **Drugs (Lithium, Aspirin, Indomethacin, Beta-blockers)
3. ***Infection
Laboratory findings:
- ***Neutrophilia
- Low albumin
- Low calcium
Management:
1. ***Withdraw culprit drugs
- ***Hospitalisation
- monitor BP, temp, Ca, FBC, U/E/Cr
- swabs for pyogenic culture - ***Anti-staphylococcal antibiotics e.g. Cloxacillin
- Specific therapy
- Methotrexate
- Acitretin (retinoid)
- Cyclosporin
- Acute Generalised Exanthematous Pustulosis (AGEP) —> DDx of Pustular psoriasis
Acute Generalised Exanthematous Pustulosis (AGEP)
- Absence of other features of psoriasis e.g. psoriatic nails
- Widespread nonfollicular pustules on edematous erythema with accentuation of skin folds
- Facial edema
- **Acute: < 10 days (*Spontaneous resolution < 15 days)
Etiology:
- Drugs (Aminopenicillin, ***Sulphonamide, Terbinafine, Diltiazem)
Clinical features:
- Acute pustular eruption
- Fever >38oC
- **Neutrophilia +/- Eosinophilia
- **Subcorneal / Intraepidermal pustules on biopsy
- ***Spontaneous resolution < 15 days
Prognosis:
- Mortality 5%
- Drug Rash with Eosinophilia and Systemic Symptoms (DRESS)
aka ***Drug Hypersensitivity Syndrome
Clinical presentation:
- Fever
- Facial edema
- Infiltrated papules
- Generalised papulopustular / exanthematous rash
- Purpura
- Scaling
- **Lymphadenopathy (Lymphoid hyperplasia)
- **Hypereosinophilia (90% of cases)
- Atypical lymphocytes / Mononucleosis (40% of cases)
***Organ involvement:
- Hepatitis
- Nephritis
- Myocarditis
- Hypothyroidism
Causative agents (SpC Medicine):
- **Allopurinol
- **Anticonvulsants (Carbamazepine, Phenytoin, Lamotrigine)
- ***Sulfonamides
Onset:
- 2-6 weeks after starting treatment (longer than AGEP)
Grading:
- ***RegiSCAR score
Pathophysiology (poorly understood):
- **Defective detoxification of reactive oxidative metabolites
- Genetic predisposition
- Slow acetylator
- **Reactivation of Human Herpes Virus 6 (HHV6)
Prognosis:
- 10% mortality
Management:
- ***Oral Steroids
- Supportive
- Stevens-Johnson syndrome (SJS) / Toxic Epidermal Necrolysis (TEN)
Start as **Target lesion —> **Diffuse erythema —> ***Skin necrosis + detachment
SJS: **<10% epidermal detachment + >=2 mucosal sites
TEN: **>30% epidermal detachment
Etiology:
- **Drug (exposure to onset: 1-3 weeks)
(SpC Medicine)
1. **Allopurinol
2. **Carbamazepine, **Phenytoin, Lamotrigine
Prodrome:
- Fever / flu-like
- Odynophagia
- Stinging pain in eyes
- Skin pain, burning + tenderness
Symptoms:
1. ***Mucous membrane
- painful + tender mouth lesions
- genital erosions
- ocular symptoms, conjunctival injection
- ***Nikolsky’s sign
- detachment of intact superficial epidermis by shearing force (一掂就甩)
- measured in Body Surface Area (BSA): palm: 1%
Sequelae:
- Integumentary system: Dyspigmentation, Onycholysis
- Ocular: Sjogren syndrome, Corneal scarring
- Pulmonary: Chronic bronchitis
- Oral cavity: Sjogren syndrome, Reduced salivary flow
- Genitourinary system: Dyspareunia
- GI system: Esophageal stricture
Prognosis:
- **High mortality rate (23-34%): **Sepsis leading multi organ failure
- Additional morbidity from GI bleeding, Pulmonary embolism, MI, Pulmonary edema
Prevention:
- Avoid potential offending agents + any cross reacting medications:
—> Antiepileptic
—> Sulfonamide
—> Beta-lactam
Genotype testing:
- HLA-B1502 before **Carbamazepine + **Phenytoin
- HLA-B5701 before Abacavir
- HLA-B5801 before **Allopurinol
Management of SJS/TEN
Assessment:
- **Haemodynamically stable
- **BSA involvement / SCORTEN scale
Investigations:
- **Blood culture
- **Wound swab of broken skin for Aerobic culture
- FBC, U/E/Cr, LFT, CXR, ECG +/- investigations for viral etiology if clinically indicated
Management (self-limiting, mainly **supportive, need early intervention):
1. **Stop causative drug
- ***IV hydration
—> first 24 hour: 4ml x weight x BSA%
—> 1st 50% in first 8 hours, 2nd 50% in subsequent 16 hours - **Foley catheter, monitor **urine output
- ***Non-adhesive dressing
- Refer to ***Dermatology / Burns unit for wound care + management
***AGEP vs DRESS vs SJS/TEN
- Onset
AGEP: 48 hours
DRESS: 2-6 weeks
SJS/TEN: 1-3 weeks - Duration
AGEP: <1 week
DRESS: several weeks
SJS/TEN: 1-3 weeks - Mucocutaneous features
AGEP: Facial edema, pustules, tense bullae, mucosal involvement, target lesions
DRESS: Facial edema, morbilliform eruption, pustules, exfoliative dermatitis, tense bullae
SJS/TEN: Bullae, atypical target lesions, ***mucocutaneous erosions
***4. Histological pattern of skin
AGEP: Subcorneal pustules
DRESS: Perivascular lymphocytic infiltrate
SJS/TEN: Epidermal necrosis
***5. Lymphadenopathy
AGEP: +
DRESS: +++ (lymphoid hyperplasia)
SJS/TEN: -
- Other organ involvement
AGEP: possible
DRESS: interstitial nephritis, pneumonitis, myocarditis, thyroiditis
SJS/TEN: tubular nephritis, tracheobronchial necrosis
***7. Neutrophils
AGEP: ↑↑↑
DRESS: ↑
SJS/TEN: ↓
***8. Eosinophils
AGEP: ↑
DRESS: ↑↑↑
SJS/TEN: -
- Atypical lymphocytes
AGEP: -
DRESS: +
SJS/TEN: - - Mortality
AGEP: 5%
DRESS: 10%
SJS/TEN: 5-35%